Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

349 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multi-level profiling unravels mitochondrial dysfunction in myotonic dystrophy type 2.
Kleefeld F, Horvath R, Pinal-Fernandez I, Mammen AL, Casal-Dominguez M, Hathazi D, Melchert S, Hahn K, Sickmann A, Muselmann-Genschow C, Hentschel A, Preuße C, Roos A, Schoser B, Stenzel W. Kleefeld F, et al. Among authors: schoser b. Acta Neuropathol. 2024 Jan 19;147(1):19. doi: 10.1007/s00401-023-02673-y. Acta Neuropathol. 2024. PMID: 38240888 Free PMC article.
Morphological and molecular comparison of HIV-associated and sporadic inclusion body myositis.
Vogt S, Kleefeld F, Preusse C, Arendt G, Bieneck S, Brunn A, Deckert M, Englert B, Goebel HH, Masuhr A, Neuen-Jacob E, Kornblum C, Reimann J, Montagnese F, Schoser B, Stenzel W, Hahn K. Vogt S, et al. Among authors: schoser b. J Neurol. 2023 Sep;270(9):4434-4443. doi: 10.1007/s00415-023-11779-y. Epub 2023 Jun 6. J Neurol. 2023. PMID: 37280376 Free PMC article.
The current clinical perception of myotonic dystrophy type 2.
Kleefeld F, Schoser B. Kleefeld F, et al. Among authors: schoser b. Curr Opin Neurol. 2023 Oct 1;36(5):474-478. doi: 10.1097/WCO.0000000000001186. Epub 2023 Jul 18. Curr Opin Neurol. 2023. PMID: 37639480 Review.
Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis.
Nelke C, Schroeter CB, Theissen L, Preusse C, Pawlitzki M, Räuber S, Dobelmann V, Cengiz D, Kleefeld F, Roos A, Schoser B, Brunn A, Neuen-Jacob E, Zschüntzsch J, Meuth SG, Stenzel W, Ruck T. Nelke C, et al. Among authors: schoser b. Acta Neuropathol. 2023 Nov;146(5):725-745. doi: 10.1007/s00401-023-02637-2. Epub 2023 Sep 29. Acta Neuropathol. 2023. PMID: 37773216 Free PMC article.
Factors associated with the severity of COVID-19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID-19 Registry.
Pizzamiglio C, Pitceathly RDS, Lunn MP, Brady S, De Marchi F, Galan L, Heckmann JM, Horga A, Molnar MJ, Oliveira ASB, Pinto WBVR, Primiano G, Santos E, Schoser B, Servidei S, Sgobbi Souza PV, Venugopalan V, Hanna MG, Dimachkie MM, Machado PM; Neuromuscular Diseases and COVID-19 Study Group. Pizzamiglio C, et al. Among authors: schoser b. Eur J Neurol. 2023 Feb;30(2):399-412. doi: 10.1111/ene.15613. Epub 2022 Nov 18. Eur J Neurol. 2023. PMID: 36303290 Free PMC article.
349 results